2023 ESC Guidelines on ACS: what is new in antithrombotic therapy?

M Galli, F Andreotti, P Sabouret, F Gragnano - 2023 - academic.oup.com
Beyond late-breaking clinical trials, the presentation of the European Society of Cardiology
(ESC) Guidelines has become a highly anticipated event at the annual ESC Congress. This …

JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease

M Nakamura, K Kimura, T Kimura, M Ishihara… - Circulation …, 2020 - jstage.jst.go.jp
In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 …

A Landi, V Aboyans, DJ Angiolillo, D Atar… - … Heart Journal: Acute …, 2024 - academic.oup.com
Antithrombotic therapy represents the cornerstone of the pharmacological treatment in
patients with acute coronary syndrome (ACS). The optimal combination and duration of …

Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients …

Authors:, JP Collet, M Roffi, C Mueller… - European heart …, 2016 - academic.oup.com
† Full text document: Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax
JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P …

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion …

E Barbato, J Mehilli, D Sibbing… - European heart …, 2021 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy

FWA Verheugt, P Clemmensen, R Mehran… - European heart …, 2013 - academic.oup.com
An intricate balance exists between the safety and efficacy of antithrombotic therapies in
acute coronary syndrome (ACS). Safety is largely defined by bleeding risks. Many bleeding …

What Is New in the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes

M Roffi - Cardiology Discovery, 2023 - mednexus.org
For the first time, European Society of Cardiology (ESC) guidelines have aggregated in 1
single document recommendations for the management of patients with non-ST-segment …

2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation: Recommendations and critical appraisal from the Dutch ACS and Interventional …

F Arslan, P Damman, B Zwart, Y Appelman… - Netherlands Heart …, 2021 - Springer
Abstract Recently, the European Society of Cardiology (ESC) has updated its guidelines for
the management of patients with acute coronary syndrome (ACS) without ST-segment …

Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines

F Van de Werf, D Ardissino, H Bueno… - Expert review of …, 2012 - Taylor & Francis
The management of acute coronary syndrome in Europe is covered by various European
Society of Cardiology guidelines, which although valuable, are complex and may not always …

NSTE-ACS ESC guidelines recommend prasugrel as the preferred P2Y12 inhibitor: a contrarian view

D Angoulvant, P Sabouret, MP Savage - American Journal of …, 2021 - Springer
Abstract In the 2020 European Society of Cardiology guidelines on non-ST-segment
elevation acute coronary syndromes (NSTE-ACS), the experts proposed to put an end to the …